Polaris Market Research today announced findings from its latest report, projecting the global AI in Oncology market to grow from USD 6.51 billion in 2025 to USD 56.44 billion by 2034, at a CAGR of 27.1%. The report profiles 10 leading companies across multiple market segments, benchmarking the global AI in oncology landscape across component, application, and regional lines. The market covers AI-powered software, hardware, and services used for cancer classification, detection, characterization, and treatment monitoring across breast, lung, prostate, colorectal, and brain cancers.

Market Overview

AI in oncology refers to the application of machine learning, deep learning, and predictive analytics to cancer classification, detection, characterization, and monitoring. Compared with traditional oncology, which relies heavily on manual image analysis and specialist interpretation, AI-powered platforms can process imaging, pathology, and molecular data far faster, improving diagnostic accuracy and shortening timelines to treatment. The technology also supports predictive analytics for estimating cancer risk and therapy response, enabling more personalized treatment planning through patient-specific genomic and clinical data analysis. Continued investment from both government and private research organizations is expanding the range of cancers and treatment types these tools can support.

Analyst Commentary on AI in Oncology Market Growth

"Precision medicine and early cancer detection capabilities are the two biggest growth drivers we are seeing, as AI-based imaging analysis is meaningfully shortening diagnosis timelines compared with manual clinical evaluation" said a Senior Research Analyst at Polaris Market Research. "Buyers evaluating this space should prioritize vendors with proven software solutions for treatment personalization, since that segment is where adoption and reimbursement momentum is strongest"

AI in Oncology Market Statistics at a Glance

• 2025 Market Size: USD 6.51 billion
• 2026 Market Estimate: USD 8.26 billion
• 2034 Projected Size: USD 56.44 billion
• CAGR (2026-2034): 27.1%
• Largest Region (2025): North America, 42.8% share
• Leading Segment (2025): Software Solutions segment, 71.5% share by component

Key Growth Drivers, Major Companies and Segments Covered

Growth Drivers: Growing demand for early cancer detection and diagnosis, rising use of AI for personalized treatment planning, and increasing integration of AI with genomic analysis and drug discovery are the primary forces behind the market's expansion. According to the World Health Organization, cancer is the leading cause of death globally, contributing to roughly one in six deaths worldwide, a scale of clinical need that is accelerating investment in AI-enabled oncology tools by both public and private organizations. Data privacy concerns, regulatory hurdles, and limited access to high-quality clinical datasets remain the primary restraints slowing broader AI adoption in the oncology segment.

Major Companies Covered: Azra AI; IBM; Siemens Healthcare GmbH; Intel Corporation; GE HealthCare; NVIDIA Corporation.

Segments Covered: By Component (Software Solutions, Hardware, Services), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Others), By Treatment Type (Chemotherapy, Radiotherapy, Immunotherapy, Others), By Region.

👉 Download a Free Sample of the AI in Oncology Market Report →  https://www.polarismarketresearch.com/industry-analysis/ai-in-oncology-market 

Recent Developments in the AI in Oncology Market

• June 2026: The National Cancer Center launched a research initiative focused on developing AI technology that can predict the likelihood of success for drug candidates before they enter the costly and time-consuming drug development process.
• December 2022: MedCognetics obtained FDA approval for QmTRIAGE, an AI-enabled platform designed for breast cancer screening intended to reduce both cost and turnaround time while improving diagnostic outcomes.

Regional Snapshot: North America Leads, Asia Pacific Fastest-Growing

North America dominated the global market with 42.8% revenue share in 2025, driven by well-established digital healthcare infrastructure, favorable reimbursement policies, and a strong presence of AI technology and oncology solution providers alongside supportive government initiatives promoting AI adoption in healthcare. Asia Pacific is projected to register the highest CAGR of 32.4% during the forecast period, attributed to rising digitalization of diagnostic laboratories and hospitals, a growing geriatric population, and increasing cancer prevalence, with the region accounting for roughly 9.7 million of the 19 million new global cancer cases reported by Globocan in 2020. Europe continues to build capacity around AI-assisted screening and treatment planning, complementing the two leading regions.

Why It Matters for Buyers Evaluating Market Entry

For stakeholders researching top companies and market forecasts in precision oncology, the underlying report benchmarks AI in oncology market share, company positioning, and treatment-type-level forecasts to support sourcing, partnership, and investment decisions through 2034. Health systems and technology vendors evaluating entry into breast cancer screening or chemotherapy personalization can use these findings to prioritize the fastest-growing regional opportunities. With the chemotherapy segment holding the largest treatment-type share, vendors offering AI-driven dosage optimization tools are especially well positioned for near-term adoption.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

battery-energy-storage-systems-bess-market-the-backbone-of-the-renewable-energy-transition

why-energy-independence-matters-more-than-ever

construction-equipment-market

carbon-black-market

air-purifier-market-boom-post-pandemic-growth-and-consumer-trends

home-healthcare-market

online-event-ticketing-market

motion-control-market

it-services-market